Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Ertapenem injection is used to treat certain serious infections, including pneumonia and urinary tract, skin, diabetic foot, gynecological, pelvic, and abdominal (stomach area) infections, that are caused by bacteria. It is also used for the prevention of infections following colorectal surgery. Ertapenem is in a class of medications called carbapenem antibiotics.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Ertapenem Injection market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Ertapenem Injection market. Detailed analysis of key players, along with key growth strategies adopted by Ertapenem Injection industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Aurobindo Pharma
ACS Dobfar
Endo
Merck
By Type:
INVANZ
Generic Version
By End-User:
Adult
Pediatric
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Ertapenem Injection Market
-
1.3 Market Segment by Type
-
1.3.1 China Ertapenem Injection Market Size and Growth Rate of INVANZ from 2016 to 2027
-
1.3.2 China Ertapenem Injection Market Size and Growth Rate of Generic Version from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Ertapenem Injection Market Size and Growth Rate of Adult from 2016 to 2027
-
1.4.2 China Ertapenem Injection Market Size and Growth Rate of Pediatric from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Ertapenem Injection Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Ertapenem Injection by Major Types
-
3.4.1 Market Size and Growth Rate of INVANZ
-
3.4.2 Market Size and Growth Rate of Generic Version
4 Segmentation of Ertapenem Injection Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Ertapenem Injection by Major End-Users
-
4.4.1 Market Size and Growth Rate of Ertapenem Injection in Adult
-
4.4.2 Market Size and Growth Rate of Ertapenem Injection in Pediatric
5 Market Analysis by Regions
-
5.1 China Ertapenem Injection Production Analysis by Regions
-
5.2 China Ertapenem Injection Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Ertapenem Injection Landscape Analysis
-
6.1 North China Ertapenem Injection Landscape Analysis by Major Types
-
6.2 North China Ertapenem Injection Landscape Analysis by Major End-Users
7 Central China Ertapenem Injection Landscape Analysis
-
7.1 Central China Ertapenem Injection Landscape Analysis by Major Types
-
7.2 Central China Ertapenem Injection Landscape Analysis by Major End-Users
8 South China Ertapenem Injection Landscape Analysis
-
8.1 South China Ertapenem Injection Landscape Analysis by Major Types
-
8.2 South China Ertapenem Injection Landscape Analysis by Major End-Users
9 East China Ertapenem Injection Landscape Analysis
-
9.1 East China Ertapenem Injection Landscape Analysis by Major Types
-
9.2 East China Ertapenem Injection Landscape Analysis by Major End-Users
10 Northeast China Ertapenem Injection Landscape Analysis
-
10.1 Northeast China Ertapenem Injection Landscape Analysis by Major Types
-
10.2 Northeast China Ertapenem Injection Landscape Analysis by Major End-Users
11 Southwest China Ertapenem Injection Landscape Analysis
-
11.1 Southwest China Ertapenem Injection Landscape Analysis by Major Types
-
11.2 Southwest China Ertapenem Injection Landscape Analysis by Major End-Users
12 Northwest China Ertapenem Injection Landscape Analysis
-
12.1 Northwest China Ertapenem Injection Landscape Analysis by Major Types
-
12.2 Northwest China Ertapenem Injection Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Aurobindo Pharma
-
13.1.1 Aurobindo Pharma Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 ACS Dobfar
-
13.2.1 ACS Dobfar Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Endo
-
13.3.1 Endo Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Merck
-
13.4.1 Merck Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Ertapenem Injection Market Size and Growth Rate of INVANZ from 2016 to 2027
-
Figure China Ertapenem Injection Market Size and Growth Rate of Generic Version from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Ertapenem Injection Market Size and Growth Rate of Adult from 2016 to 2027
-
Figure China Ertapenem Injection Market Size and Growth Rate of Pediatric from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Ertapenem Injection Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Ertapenem Injection Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Ertapenem Injection
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Ertapenem Injection by Different Types from 2016 to 2027
-
Table Consumption Share of Ertapenem Injection by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of INVANZ
-
Figure Market Size and Growth Rate of Generic Version
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Ertapenem Injection by Different End-Users from 2016 to 2027
-
Table Consumption Share of Ertapenem Injection by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Adult
-
Figure Market Size and Growth Rate of Pediatric
-
Table China Ertapenem Injection Production by Regions
-
Table China Ertapenem Injection Production Share by Regions
-
Figure China Ertapenem Injection Production Share by Regions in 2016
-
Figure China Ertapenem Injection Production Share by Regions in 2021
-
Figure China Ertapenem Injection Production Share by Regions in 2027
-
Table China Ertapenem Injection Consumption by Regions
-
Table China Ertapenem Injection Consumption Share by Regions
-
Figure China Ertapenem Injection Consumption Share by Regions in 2016
-
Figure China Ertapenem Injection Consumption Share by Regions in 2021
-
Figure China Ertapenem Injection Consumption Share by Regions in 2027
-
Table North China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table North China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure North China Ertapenem Injection Consumption Share by Types in 2016
-
Figure North China Ertapenem Injection Consumption Share by Types in 2021
-
Figure North China Ertapenem Injection Consumption Share by Types in 2027
-
Table North China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table North China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure North China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure North China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure North China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table Central China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table Central China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure Central China Ertapenem Injection Consumption Share by Types in 2016
-
Figure Central China Ertapenem Injection Consumption Share by Types in 2021
-
Figure Central China Ertapenem Injection Consumption Share by Types in 2027
-
Table Central China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table Central China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure Central China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure Central China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table South China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table South China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure South China Ertapenem Injection Consumption Share by Types in 2016
-
Figure South China Ertapenem Injection Consumption Share by Types in 2021
-
Figure South China Ertapenem Injection Consumption Share by Types in 2027
-
Table South China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table South China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure South China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure South China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure South China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table East China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table East China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure East China Ertapenem Injection Consumption Share by Types in 2016
-
Figure East China Ertapenem Injection Consumption Share by Types in 2021
-
Figure East China Ertapenem Injection Consumption Share by Types in 2027
-
Table East China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table East China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure East China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure East China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure East China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table Northeast China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table Northeast China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Ertapenem Injection Consumption Share by Types in 2016
-
Figure Northeast China Ertapenem Injection Consumption Share by Types in 2021
-
Figure Northeast China Ertapenem Injection Consumption Share by Types in 2027
-
Table Northeast China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table Northeast China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure Northeast China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure Northeast China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table Southwest China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table Southwest China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Ertapenem Injection Consumption Share by Types in 2016
-
Figure Southwest China Ertapenem Injection Consumption Share by Types in 2021
-
Figure Southwest China Ertapenem Injection Consumption Share by Types in 2027
-
Table Southwest China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table Southwest China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure Southwest China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure Southwest China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table Northwest China Ertapenem Injection Consumption by Types from 2016 to 2027
-
Table Northwest China Ertapenem Injection Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Ertapenem Injection Consumption Share by Types in 2016
-
Figure Northwest China Ertapenem Injection Consumption Share by Types in 2021
-
Figure Northwest China Ertapenem Injection Consumption Share by Types in 2027
-
Table Northwest China Ertapenem Injection Consumption by End-Users from 2016 to 2027
-
Table Northwest China Ertapenem Injection Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Ertapenem Injection Consumption Share by End-Users in 2016
-
Figure Northwest China Ertapenem Injection Consumption Share by End-Users in 2021
-
Figure Northwest China Ertapenem Injection Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Aurobindo Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aurobindo Pharma
-
Figure Sales and Growth Rate Analysis of Aurobindo Pharma
-
Figure Revenue and Market Share Analysis of Aurobindo Pharma
-
Table Product and Service Introduction of Aurobindo Pharma
-
Table Company Profile and Development Status of ACS Dobfar
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ACS Dobfar
-
Figure Sales and Growth Rate Analysis of ACS Dobfar
-
Figure Revenue and Market Share Analysis of ACS Dobfar
-
Table Product and Service Introduction of ACS Dobfar
-
Table Company Profile and Development Status of Endo
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Endo
-
Figure Sales and Growth Rate Analysis of Endo
-
Figure Revenue and Market Share Analysis of Endo
-
Table Product and Service Introduction of Endo
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
